These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 33796449)

  • 1. m
    Chen L; Hu B; Song X; Wang L; Ju M; Li Z; Zhou C; Zhang M; Wei Q; Guan Q; Jiang L; Chen T; Wei M; Zhao L
    Front Oncol; 2021; 11():598017. PubMed ID: 33796449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis.
    Yang F; Zhao G; Ge L; Song Y; Hong K; Zhang H; Liu C; Hong P; Ma L
    Biomed Res Int; 2021; 2021():4582082. PubMed ID: 33628782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a m
    Zhao X; Cui L
    Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer.
    Guo Y; Bai Y; Wang L; Xu Z; Wang X; Wang W
    Medicine (Baltimore); 2022 Jul; 101(26):e29818. PubMed ID: 35777046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma.
    Sun Z; Jing C; Xiao C; Li T; Wang Y
    Aging (Albany NY); 2020 Nov; 12(21):22078-22094. PubMed ID: 33177247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of an m6A RNA methylation regulator prognostic model for early-stage clear cell renal cell carcinoma.
    Wang Z; Zhang M; Seery S; Zheng G; Wang W; Zhao Y; Wang X; Zhang Y
    Oncol Lett; 2022 Aug; 24(2):250. PubMed ID: 35761938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
    Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
    Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Validation of a Ferroptosis-Related Signature for Predicting Prognosis and Immune Microenvironment in Papillary Renal Cell Carcinoma.
    Da Q; Ren M; Huang L; Qu J; Yang Q; Xu J; Ma Q; Mao X; Cai Y; Zhao D; Luo J; Yan Z; Sun L; Ouyang K; Zhang X; Han Z; Liu J; Wang T
    Int J Gen Med; 2022; 15():2963-2977. PubMed ID: 35313551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of molecular subtypes based on chromatin regulator and tumor microenvironment infiltration characterization in papillary renal cell carcinoma.
    Tang Q; Pan D; Xu C; Chen L
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):231-245. PubMed ID: 36404389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. m
    Hou J; Shan H; Zhang Y; Fan Y; Wu B
    Am J Otolaryngol; 2020; 41(4):102547. PubMed ID: 32474328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of the Role of m
    Wei Q; Yang D; Liu X; Zhao H; Yang Y; Xu J; Liu T; Yi P
    Front Genet; 2021; 12():650554. PubMed ID: 34149801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma.
    Yu ZH; Feng ST; Zhang D; Cao XC; Yu Y; Wang X
    Cancer Cell Int; 2021 Jul; 21(1):385. PubMed ID: 34281544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular subtypes of m
    Guan B; Ren F; Shan W; Zhang S
    Transl Cancer Res; 2022 Mar; 11(3):508-518. PubMed ID: 35402182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer.
    Xu LC; Pan JX; Pan HD
    Cancer Manag Res; 2020; 12():5385-5394. PubMed ID: 32753956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The methylation modification of m6A regulators contributes to the prognosis of head and neck squamous cell carcinoma.
    Chen Y; Jiang X; Li X; Yan D; Liu J; Yang J; Yan S
    Ann Transl Med; 2021 Aug; 9(16):1346. PubMed ID: 34532483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer.
    Chen M; Nie ZY; Wen XH; Gao YH; Cao H; Zhang SF
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31808521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics profiling integrating a four immune-related long non-coding RNAs signature as a prognostic model for papillary renal cell carcinoma.
    Liu Y; Gou X; Wei Z; Yu H; Zhou X; Li X
    Aging (Albany NY); 2020 Jul; 12(15):15359-15373. PubMed ID: 32716909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of New m
    Zheng B; Cheng F; Yao Z; Zhang Y; Cong Z; Wang J; Niu Z; He W
    Front Cell Dev Biol; 2022; 10():818194. PubMed ID: 35372339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma.
    Liu J; Zhou Z; Ma L; Li C; Lin Y; Yu T; Wei JF; Zhu L; Yao G
    Cancer Cell Int; 2021 Aug; 21(1):453. PubMed ID: 34446007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.